First-in-human study assessing safety, tolerability, and pharmacokinetics of 2-hydroxybenzylamine acetate, a selective dicarbonyl electrophile scavenger, in healthy volunteers

Peer Review reports

Original Submission
10 Sep 2018	Submitted	Original manuscript
22 Nov 2018	Reviewed	Reviewer Report - John Ashton
29 Nov 2018	Reviewed	Reviewer Report - Aniella Abi-Gerges
13 Dec 2018	Author responded	Author comments - Lisa Pitchford
Resubmission - Version 2
13 Dec 2018	Submitted	Manuscript version 2
Publishing
20 Dec 2018	Editorially accepted
5 Jan 2019	Article published	10.1186/s40360-018-0281-7

Back to article page